Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021.

Creedon, Timothy B; Ali, Mir M; Schuman-Olivier, Zev

Creedon, Timothy B; Ali, Mir M; Schuman-Olivier, Zev.

Afiliación

Creedon TB; Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.
Ali MM; Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.
Schuman-Olivier Z; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

JAMA Health Forum ; 4(4): e230221, 2023 04 07.

Article en En | MEDLINE | ID: mdl-37027166

This cross-sectional study uses data from a database to compare national trends in patients treated with buprenorphine by psychiatrists and nonpsychiatrists from 2003 to 2021.

Asunto(s)

Buprenorfina; Trastornos Relacionados con Opioides; Psiquiatría; Humanos; Buprenorfina/uso terapéutico; Trastornos Relacionados con Opioides/tratamiento farmacológico; Trastornos Relacionados con Opioides/epidemiología; Antagonistas de Narcóticos/uso terapéutico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 2_sustancias_psicoativas / 8_opioid_abuse Asunto principal: Psiquiatría / Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Health Forum Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google